Literature DB >> 27628176

Clinical Manifestations, Complications and Treatment of Ocular Sarcoidosis: Correlation between Visual Efficiency and Macular Edema as Seen on Optical Coherence Tomography.

Jelena Paovic1, Predrag Paovic1, Vojislav Sredovic2, Svetlana Jovanovic3.   

Abstract

Sarcoidosis is a chronic systemic autoimmune disease which belongs to a group of systemic granulomatous diseases. It can be confirmed through characteristic systemic and ocular manifestations and histological findings. Biopsy is the golden standard for diagnosing sarcoidosis. Ocular sarcoidosis can be confirmed, probable, or possible. Over a two-year period, ocular manifestations were studied on a sample of 52 patients, each followed for four months and diagnosed with some form of systemic sarcoidosis. Most frequent systemic manifestations in patients with ocular sarcoidosis were pulmonary, skin, glandular, and systemic generalized sarcoidosis. The disease was diagnosed four times more frequently in females than males (42:10, respectively; p < 0.05). Most frequent, and statistically significant, manifestation of ocular sarcoidosis is anterior uveitis (64.61%; p < 0.01). Macular edema and periphlebitis associated with periarteritis were frequent, and statistically significant (43.90% and 29.26%, respectively; p < 0.05). Overall, with regards to gender and location (right eye; left eye), visual acuity was >0.5 and of statistical significance (76.92%; p < 0.01). The most common therapy consisted of systemic corticosteroids (26.67%) and/or a combination of corticosteroids and immunosuppressive drugs (23.33%). In 16 eyes treated with repeated doses of sub-Tenon's injections, both initial and control visual acuity correlated with average thickness. There was positive correlation between several optical coherence tomography findings before and after treatment.

Entities:  

Keywords:  Macular edema; ocular manifestations; peripheral retinal laser photocoagulation; sub-Tenon’s Triamcinolone acetonide; systemic sarcoidosis; treatment

Year:  2016        PMID: 27628176     DOI: 10.1080/08820538.2016.1206576

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  6 in total

Review 1.  Ocular sarcoidosis: new diagnostic modalities and treatment.

Authors:  Sung J Yang; Sherveen Salek; James T Rosenbaum
Journal:  Curr Opin Pulm Med       Date:  2017-09       Impact factor: 3.155

Review 2.  Pathogenesis of Uveitic Glaucoma.

Authors:  Dimitrios Kalogeropoulos; Velota Ct Sung
Journal:  J Curr Glaucoma Pract       Date:  2018 Sep-Dec

Review 3.  Sarcoid Uveitis: An Intriguing Challenger.

Authors:  Pia Allegri; Sara Olivari; Federico Rissotto; Roberta Rissotto
Journal:  Medicina (Kaunas)       Date:  2022-07-04       Impact factor: 2.948

4.  Management of Non-Infectious Uveitis, a Selection of Topical Items Updating.

Authors:  Pascal Sève; Thomas El Jammal; Mathieu Gerfaud-Valentin; Laurent Kodjikian; Yvan Jamilloux; Robin Jacquot
Journal:  J Clin Med       Date:  2022-09-22       Impact factor: 4.964

Review 5.  Extrapulmonary sarcoidosis with a focus on cardiac, nervous system, and ocular involvement.

Authors:  John A Belperio; Faisal Shaikh; Fereidoun Abtin; Michael C Fishbein; Rajan Saggar; Edmund Tsui; Joseph P Lynch
Journal:  EClinicalMedicine       Date:  2021-06-27

Review 6.  Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis.

Authors:  Pascal Sève; Yves Pacheco; François Durupt; Yvan Jamilloux; Mathieu Gerfaud-Valentin; Sylvie Isaac; Loïc Boussel; Alain Calender; Géraldine Androdias; Dominique Valeyre; Thomas El Jammal
Journal:  Cells       Date:  2021-03-31       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.